BDX
$218.61
Becton Dickinson
($1.07)
(.49%)
BDX
Earnings Whisper ®
N/A
1st Quarter December 2017
Consensus:  $2.43
Revenue:  $3.04 Bil
Thursday
Feb 1
6:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BDX reports earnings?
Beat
Meet
Miss

Where is BDX's stock price going from here?
Up
Flat
Down
Stock chart of BDX
Analysts
Summary of analysts' recommendations for BDX
Score
Grade
Pivots
Resistance
$223.93
$222.19
$220.93

$219.19

Support
$217.93
$216.19
$214.93
Tweet
Growth
Description
Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BD's operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.
Peers
Abbott LaboratoriesBoston ScientificStrykerC. R. BardBaxter InternationalWatersIntegra LifeSciences Holdings3MResMedAbiomed